IRCT138711201548N3Completed未知
A comparison between the effect of vaginal probiotic capsules and the oral tablet of Metronidazol on combined bacterial and trichomonial vaginitis in selected gynecology clinics of Shiraz University of Medical Science, 1390
Deputy for Research of Shiraz University of Medical Sciences0 sites100 target enrollmentStarted: TBDLast updated:
Conditions
Trial Snapshot
- Phase
- 未知
- Status
- Completed
- Sponsor
- Enrollment
- 100
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 18 years to 55 years (—)
- Sex
- Female
Inclusion Criteria
- •Inclusion criteria of the study: Non-pregnant, non-lactating, and non-smoker women who aged between 18 and 55, being married, being willing to participate in the research, being in the follicular phase of the menstrual cycle, having signs of trichomoniasis on physical examination, having signs of bacterial vaginosis on physical examination, not having abnormal vaginal bleeding at the time of sampling, not having vaginal intercourse and douching during 48 hours prior to the study, not taking vaginal medication, such as creams, suppositories, and vaginal disinfectants in 48 hours before the study, not taking medication for treatment during the last 3 months, not suffering from specific diseases, such as liver, heart, and kidney diseases, diabetes, central nervous system diseases, blood discrasia, immune system defects, and known sexually transmitted diseases, not having used broad-spectrum antibiotics, anti-prostaglandins, hormone and immunosuppressive drugs, alcohol, and anticoagulation in recent months, no history of sensitivity to metronidazole tablets, not having vulvovaginitis four or more times during the year, and not having multiple sexual partners.
- •Exclusion criteria of the study: Having allergy to the elements of the probiotic products which were used in the study, being considered unhealthy based on the clinical diagnosis, while having negative test results, and having allergy to the medication compounds used in the study.
Exclusion Criteria
- Not provided
Investigators
Similar Trials
Recruiting
Phase 3
The effect of vaginal probiotic on perinatal outcome in patient with premature rupture of fetal membranespremature rupture of fetal membranes.premature rupture of fetal membranesIRCT20200921048790N1Sanandaj University of Medical Sciences108
Recruiting
Phase 3
Investigation of the effects of vaginal probiotic capsules on prolonging the time of membrane rupture up to delivery and on maternal and fetal complications.IRCT20141209020264N3Mashhad University of Medical Sciences64
Recruiting
Phase 2
The Determining the effect of vaginal probiotics on perinatal outcomesPreterm spontaneous labour with term delivery.Preterm spontaneous labour with term deliveryO60.2IRCT20160523028008N30Hamedan University of Medical Sciences106
Recruiting
Phase 3
Investigating the effect of vaginal probiotics on the consequences of embryo transfer, microbial culture of the uterine cavity and vagina in infertile women undergoing embryo transfer.EndometriosisIRCT20110602006689N5Tehran University of Medical Sciences156
Completed
Not Applicable
Effect of vaginal probiotic on bacterial vaginosis and vaginal candidiasisCondition 1: vulvitis and vulvovaginal candida. Condition 2: bacterial vaginosise.Candidiasis of vulva and vaginainflammation of vagina and vulvaIRCT2014050617603N1Vice chancellor for Research, Shiraz University of Medical Sciences140